OCUL
Ocular Therapeutix, Inc. · Healthcare
Chief Scientific Officer Jeffrey S. Heier sold $27K of Ocular Therapeutix, Inc.
Sold$26,561
$9.01Price
2,948Shares
−1%Stake
What OCUL did after the filing
- The stock from Wed, Nov 27 open, $9.69
- −18.9%
- S&P 500, same days
- −2.7%
Measured over 30 trading days, to the Jan 14 close.
Traded Mon, Nov 25. Filed Wed, Nov 27, 2:52 AM ET, before the open. Returns use the Nov 27 open and the Jan 14 close. Not investment advice.